NEW YORK (GenomeWeb News) – Decode Genetics reported after the close of the market on Wednesday that its second-quarter revenues nearly doubled to $15 million from $7.6 million year over year.
 
The Reykjavik, Iceland-based biopharmaceutical and molecular diagnostics firm noted in a statement that it also has $15.1 million in deferred revenue that will be recognized over future reporting periods.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.